Immunohistochemistry (IHC) Market Size, Share, and Trends Analysis Report
CAGR :
| Market Size 2023 (Base Year) | USD 2.49 Billion |
| Market Size 2032 (Forecast Year) | USD 4.37 Billion |
| CAGR | 5.80% |
| Forecast Period | 2024 - 2032 |
| Historical Period | 2018 - 2022 |
Immunohistochemistry (IHC) Market Insights
Market Research Store has published a report on the global Immunohistochemistry (IHC) Market, estimating its value at USD 2.49 Billion in 2023, with projections indicating that it will reach USD 4.37 Billion by 2032. The market is expected to expand at a compound annual growth rate (CAGR) of 5.8% over the forecast period 2024-2032. The report explores the factors fueling market growth, the hitches that could hamper this expansion, and the opportunities that may arise in the Immunohistochemistry (IHC) Market industry. Additionally, it offers a detailed analysis of how these elements will affect market demand dynamics and market performance throughout the forecast period.
-market-size.png)
To Get more Insights, Request a Free Sample
The report offers an assessment and analysis of the Immunohistochemistry (IHC) market on a global and regional level. The study offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD Billion).
Immunohistochemistry (IHC) Market: Overview
Immunohistochemistry or IHC is a technique that makes effective use of monoclonal & polyclonal antibodies for identifying particular kinds of antigens in tissues, thereby identifying various types of diseases in the person. The IHC technique is divided into two phases: i) preparation of slides & stages involved in the reaction and ii) interpreting & quantifying the gene expression that is derived. Additionally, Immunohistochemistry plays a pivotal role in scientific research activities and the interpretation of differential diagnoses that cannot be determined through conventional analysis with the help of eosin and hematoxylin. It is also utilized in pathology, majorly in domains of pathology including hematopathology, oncologic pathology, and neuropathology. Furthermore, Immunohistochemistry is the combination of immunology & histology.
Immunohistochemistry (IHC) Market: Growth Factors
The surge in the occurrence of chronic ailments and a rise in drug discovery activities will manifest in the humungous growth of the immunohistochemistry (IHC) industry over 2024 – 2032. Apart from this, massive need for diagnosing cancer, heart disorders, and other viral ailments such as Swine Flu, Bird Flu, and COVID has unleashed the significance of immunohistochemistry in healthcare, thereby driving market trends. In addition to this, regulatory approvals as well as the launching of new products will steer the expansion of the immunohistochemistry (IHC) industry over the assessment timeline. Nonetheless, huge costs of automated IHC devices can badly hit the expansion of the market over the assessment timespan. However, a paradigm shift in the healthcare sector will drastically transform & turn the phase of market growth in the near future.
Furthermore, the rise in the diagnostic units and clinics along with the rise in the cases of life-threatening ailments will prop up the expansion of the immunohistochemistry (IHC) market over 2024 – 2032. The surge in cancer cases as well as the bulging elderly population prone to chronic ailments will help the market explore new dimensions of growth in the foreseeable future.
To Get more Insights, Request a Free Sample
Immunohistochemistry (IHC) Market: Report Scope
| Report Attributes | Report Details |
|---|---|
| Report Name | Immunohistochemistry (IHC) Market |
| Market Size in 2023 | USD 2.49 Billion |
| Market Forecast in 2032 | USD 4.37 Billion |
| Growth Rate | CAGR of 5.8% |
| Number of Pages | 155 |
| Key Companies Covered | Perkinelmer, Inc.; Thermo Fisher Scientific, Inc.; Agilent Technologies, Inc.; Danaher Corporation; F. Hoffmann-La Roche Ltd.; Cell Signaling Technology, Inc.; Merck KGaA; Bio-Rad Laboratories, Inc.; Bio SB; and Abcam plc. |
| Segments Covered | By Product, By End-User, By Application, And By Region |
| Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
| Base Year | 2023 |
| Historical Year | 2018 to 2022 |
| Forecast Year | 2024 - 2032 |
| Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
Immunohistochemistry (IHC) Market:? Regional Landscape
Asia Pacific Market To Exude Fastest Growth Over 2024 – 2032
Untapped growth potential in the emerging economies of the Asia Pacific zone will help the Immunohistochemistry (IHC) market enter a new phase of growth in the coming years. The surge in chronic disorders in India, South Korea, Bangladesh, China, Singapore, and the Philippines has contributed immensely towards regional market size in recent years. Population explosion and surge in the geriatric population in the countries like India and China will proliferate the regional market expansion over the assessment period.
Immunohistochemistry (IHC) Market: Competitive Landscape
Key players profiled in the study are
- Perkinelmer, Inc.
- Thermo Fisher Scientific, Inc.
- Agilent Technologies, Inc.
- Danaher Corporation
- F. Hoffmann-La Roche Ltd.
- Cell Signaling Technology, Inc.
- Merck KGaA
- Bio-Rad Laboratories, Inc.
- Bio SB
- Abcam plc.
The global Immunohistochemistry (IHC) Market is segmented as follows:
By Product
- Antibodies
- Kits
- REAGENTS
By End-User
- Hospitals
- Academic
- Diagnostic Labs
By Application
- Forensic
- Diagnostic
- Research
By Region
- North America
- The U.S.
- Canada
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
Frequently Asked Questions
Table Of Content
- Chapter 1. Preface
- 1.1. Report Description and Scope
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Type
- 1.3.2. Market Research Methodology
- Chapter 2. Executive Summary
- 2.1. Immunohistochemistry (IHC) Market, 2016–2026(USD Billion)
- 2.2. Immunohistochemistry (IHC) Market: Snapshot
- Chapter 3. Global Immunohistochemistry (IHC) Market–Analysis
- 3.1. Immunohistochemistry (IHC) Market: Market Dynamics
- 3.2. Market Drivers
- 3.2.1. Rise in the diagnostic units and clinics along with rise in the cases of life-threatening ailments will prop up the expansion of immunohistochemistry (IHC) market over 2020-2026.
- 3.2.2. Surge in the cancer cases as well as bulging elderly population prone to chronic ailments will help the market explore new dimensions of growth in the foreseeable future.
- 3.3. Porter’s Five Forces Analysis
- 3.4. Market Attractiveness Analysis
- 3.4.1. Market attractiveness analysis By Product
- 3.4.2. Market attractiveness analysis By End-User
- 3.4.3. Market attractiveness analysis By Application
- Chapter 4. Global Immunohistochemistry (IHC) Market– Competitive Landscape
- 4.1. Company market share analysis
- 4.1.1. Global Immunohistochemistry (IHC) Market: company market share, 2019
- 4.2. Strategic development
- 4.2.1. Acquisitions & mergers
- 4.2.2. New Technology launches
- 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4. Research and development and Regional expansion
- 4.3. Price trend analysis
- 4.1. Company market share analysis
- Chapter 5. Global Immunohistochemistry (IHC) Market– Product Analysis
- 5.1. Global Immunohistochemistry (IHC) Market overview: By Product
- 5.1.1. Global Immunohistochemistry (IHC) Market share, By Product, 2019 and 2026
- 5.2. Antibodies
- 5.2.1. Global Immunohistochemistry (IHC) Market by Antibodies, 2016–2026(USD Billion)
- 5.3. Kits
- 5.3.1. Global Immunohistochemistry (IHC) Market by Kits, 2016–2026(USD Billion)
- 5.4. REAGENTS
- 5.4.1. Global Immunohistochemistry (IHC) Market by REAGENTS, 2016–2026(USD Billion)
- 5.1. Global Immunohistochemistry (IHC) Market overview: By Product
- Chapter 6. Global Immunohistochemistry (IHC) Market– End-User Analysis
- 6.1. Global Immunohistochemistry (IHC) Market overview: By End-User
- 6.1.1. Global Immunohistochemistry (IHC) Market share, By End-User, 2019 and 2026
- 6.2. Hospitals
- 6.2.1. Global Immunohistochemistry (IHC) Market by Hospitals, 2016–2026(USD Billion)
- 6.3. Academic
- 6.3.1. Global Immunohistochemistry (IHC) Market by Academic, 2016–2026(USD Billion)
- 6.4. Diagnostic Labs
- 6.4.1. Global Immunohistochemistry (IHC) Market by Diagnostic Labs, 2016–2026(USD Billion)
- 6.1. Global Immunohistochemistry (IHC) Market overview: By End-User
- Chapter 7. Global Immunohistochemistry (IHC) Market– Application Analysis
- 7.1. Global Immunohistochemistry (IHC) Market overview: By Application
- 7.1.1. Global Immunohistochemistry (IHC) Market share, By Application, 2019 and 2026
- 7.2. Forensic
- 7.2.1. Global Immunohistochemistry (IHC) Market by Forensic, 2016–2026(USD Billion)
- 7.3. Diagnostics
- 7.3.1. Global Immunohistochemistry (IHC) Market by Diagnostics, 2016–2026(USD Billion)
- 7.4. Research
- 7.4.1. Global Immunohistochemistry (IHC) Market by Research, 2016–2026(USD Billion)
- 7.1. Global Immunohistochemistry (IHC) Market overview: By Application
- Chapter 8. Company Profiles
- 8.1. Perkinelmer, Inc.
- 8.1.1. Overview
- 8.1.2. Financials
- 8.1.3. Technology Portfolio
- 8.1.4. Business Strategy
- 8.1.5. Recent Developments
- 8.2. Thermo Fisher Scientific, Inc.;
- 8.2.1. Overview
- 8.2.2. Financials
- 8.2.3. Technology Portfolio
- 8.2.4. Business Strategy
- 8.2.5. Recent Developments
- 8.3. Agilent Technulogies, Inc.;
- 8.3.1. Overview
- 8.3.2. Financials
- 8.3.3. Technology Portfolio
- 8.3.4. Business Strategy
- 8.3.5. Recent Development
- 8.4. Danaher Corporation;
- 8.4.1. Overview
- 8.4.2. Financials
- 8.4.3. Technology Portfolio
- 8.4.4. Business Strategy
- 8.4.5. Recent Development
- 8.5. F. Hoffmann-La Roche Ltd.
- 8.5.1. Overview
- 8.5.2. Financials
- 8.5.3. Technology Portfolio
- 8.5.4. Business Strategy
- 8.5.5. Recent Development
- 8.6. Cell Signaling Technology, Inc.;
- 8.6.1. Overview
- 8.6.2. Financials
- 8.6.3. Technology Portfolio
- 8.6.4. Business Strategy
- 8.6.5. Recent Development
- 8.7. Merck KGaA
- 8.7.1. Overview
- 8.7.2. Financials
- 8.7.3. Technology Portfolio
- 8.7.4. Business Strategy
- 8.7.5. Recent Development
- 8.8. Bio-Rad Laboratories, Inc.
- 8.8.1. Overview
- 8.8.2. Financials
- 8.8.3. Technology Portfolio
- 8.8.4. Business Strategy
- 8.8.5. Recent Development
- 8.9. Bio SB
- 8.9.1. Overview
- 8.9.2. Financials
- 8.9.3. Technology Portfolio
- 8.9.4. Business Strategy
- 8.9.5. Recent Development
- 8.10. Abcam plc
- 8.10.1. Overview
- 8.10.2. Financials
- 8.10.3. Technology Portfolio
- 8.10.4. Business Strategy
- 8.10.5. Recent Development
- 8.1. Perkinelmer, Inc.
Inquiry For Buying
Immunohistochemistry (IHC)
Request Sample
Immunohistochemistry (IHC)
